The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells

English version České info

The mechanisms by which human immunodeficiency virus type 1 (HIV-1) crosses mucosal surfaces to establish infection are unknown. Acidic genital secretions of HIV-1-infected women contain HIV-1 likely coated by antibody. We found that the combination of acidic pH and Env-specific IgG, including that from cervicovaginal and seminal fluids of HIV-1-infected individuals, augmented transcytosis across epithelial cells as much as 20-fold compared with Env-specific IgG at neutral pH or non-specific IgG at either pH. Enhanced transcytosis was observed with clinical HIV-1 isolates, including transmitted/founder strains, and was eliminated in Fc neonatal receptor (FcRn)-knockdown epithelial cells. Non-neutralizing antibodies allowed similar or less transcytosis than neutralizing antibodies. However, the ratio of total:infectious virus was higher for neutralizing antibodies, indicating that they allowed transcytosis while blocking infectivity of transcytosed virus. Immunocytochemistry revealed abundant FcRn expression in columnar epithelia lining the human endocervix and penile urethra. Acidity and Env-specific IgG enhance transcytosis of virus across epithelial cells via FcRn and could facilitate translocation of virus to susceptible target cells following sexual exposure.

Vyšlo v časopise: The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells. PLoS Pathog 9(11): e32767. doi:10.1371/journal.ppat.1003776
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003776

Souhrn

Zdroje

1. CohenMS (2004) HIV and sexually transmitted diseases: lethal synergy. Top HIV Med 12: 104–107.

2. GalvinSR, CohenMS (2004) The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2: 33–42.

3. FanibundaSE, ModiDN, GokralJS, BandivdekarAH (2011) HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases. PLoS One 6: e28014.

4. MesmanAW, GeijtenbeekTB (2012) Pattern Recognition Receptors in HIV Transmission. Front Immunol 3: 59.

5. BallweberL, RobinsonB, KregerA, FialkowM, LentzG, et al. (2011) Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells. J Virol 85: 13443–13447.

6. KageA, ShoolianE, RokosK, OzelM, NuckR, et al. (1998) Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticles. J Virol 72: 4231–4236.

7. SaidiH, MagriG, CarbonneilC, BouhlalH, HociniH, et al. (2009) Apical interactions of HIV type 1 with polarized HEC-1 cell monolayer modulate R5-HIV type 1 spread by submucosal macrophages. AIDS Res Hum Retroviruses 25: 497–509.

8. BobardtMD, ChatterjiU, SelvarajahS, Van der SchuerenB, DavidG, et al. (2007) Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol 81: 395–405.

9. ShenR, DrelichmanER, BimczokD, OchsenbauerC, KappesJC, et al. (2010) GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium. J Immunol 184: 3648–3655.

10. CannonG, YiY, NiH, StoddardE, ScalesDA, et al. (2008) HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection. J Immunol 181: 2065–2070.

11. ViardM, ParoliniI, RawatSS, FecchiK, SargiacomoM, et al. (2004) The role of glycosphingolipids in HIV signaling, entry and pathogenesis. Glycoconj J 20: 213–222.

12. AlfsenA, YuH, Magerus-ChatinetA, SchmittA, BomselM (2005) HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol Biol Cell 16: 4267–4279.

13. StoddardE, CannonG, NiH, KarikoK, CapodiciJ, et al. (2007) gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J Immunol 179: 3126–3132.

14. StoddardE, NiH, CannonG, ZhouC, KallenbachN, et al. (2009) gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J Virol 83: 8596–8603.

15. RauxM, FinkielsztejnL, Salmon-CeronD, BouchezH, ExclerJL, et al. (2000) IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res Hum Retroviruses 16: 583–594.

16. WrightPF, KozlowskiPA, RybczykGK, GoepfertP, StaatsHF, et al. (2002) Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses 18: 1291–1300.

17. YatesNL, StaceyAR, NolenTL, VandergriftNA, MoodyMA, et al. (2013) HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. Mucosal Immunol 6 (4) 692–703.

18. MesteckyJ, JacksonS, MoldoveanuZ, NesbitLR, KulhavyR, et al. (2004) Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res Hum Retroviruses 20: 972–988.

19. LiZ, PalaniyandiS, ZengR, TuoW, RoopenianDC, et al. (2011) Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci U S A 108: 4388–4393.

20. KuoTT, BakerK, YoshidaM, QiaoSW, AvesonVG, et al. (2010) Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol 30: 777–789.

21. RoopenianDC, SunVZ (2010) Clinical ramifications of the MHC family Fc receptor FcRn. J Clin Immunol 30: 790–797.

22. AkileshS, ChristiansonGJ, RoopenianDC, ShawAS (2007) Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 179: 4580–4588.

23. SimisterNE, StoryCM, ChenHL, HuntJS (1996) An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur J Immunol 26: 1527–1531.

24. RaghavanM, GastinelLN, BjorkmanPJ (1993) The class I major histocompatibility complex related Fc receptor shows pH-dependent stability differences correlating with immunoglobulin binding and release. Biochemistry 32: 8654–8660.

25. LinharesIM, SummersPR, LarsenB, GiraldoPC, WitkinSS (2011) Contemporary perspectives on vaginal pH and lactobacilli. Am J Obstet Gynecol 204: 120 e121–125.

26. CaillouetteJC, SharpCFJr, ZimmermanGJ, RoyS (1997) Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol 176: 1270–1275 discussion 1275–1277.

27. AtashiliJ, PooleC, NdumbePM, AdimoraAA, SmithJS (2008) Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22: 1493–1501.

28. BouvetJP, GresenguetG, BelecL (1997) Vaginal pH neutralization by semen as a cofactor of HIV transmission. Clin Microbiol Infect 3: 19–23.

29. FoxCA, MeldrumSJ, WatsonBW (1973) Continuous measurement by radio-telemetry of vaginal pH during human coitus. J Reprod Fertil 33: 69–75.

30. NugentSG, KumarD, RamptonDS, EvansDF (2001) Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut 48: 571–577.

31. LiscoA, MunawwarA, IntroiniA, VanpouilleC, SabaE, et al. (2012) Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network. J Infect Dis 205: 97–105.

32. ShethPM, KovacsC, KemalKS, JonesRB, RaboudJM, et al. (2009) Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 23: 2050–2054.

33. HawesSE, SowPS, SternJE, CritchlowCW, GottliebGS, et al. (2008) Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding. AIDS 22: 2517–2525.

34. YoshidaM, ClaypoolSM, WagnerJS, MizoguchiE, MizoguchiA, et al. (2004) Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20: 769–783.

35. MaidjiE, McDonaghS, GenbacevO, TabataT, PereiraL (2006) Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168: 1210–1226.

36. MartinWL, WestAPJr, GanL, BjorkmanPJ (2001) Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol Cell 7: 867–877.

37. HintonPR, JohlfsMG, XiongJM, HanestadK, OngKC, et al. (2004) Engineered human IgG antibodies with longer serum half-lives in primates. J Biol Chem 279: 6213–6216.

38. MathurA, AroraT, LiuL, Crouse-ZeineddiniJ, MukkuV (2013) Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics. J Immunol Methods 390: 81–91.

39. LeeCH, ChoiDK, ChoiHJ, SongMY, KimYS (2010) Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris. Protein Expr Purif 71: 42–48.

40. WatkinsJD, et al. (2013) Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission. AIDS 27 (9) F13–20.

41. RamalingamTS, DetmerSA, MartinWL, BjorkmanPJ (2002) IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution. EMBO J 21: 590–601.

42. StoryCM, MikulskaJE, SimisterNE (1994) A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J Exp Med 180: 2377–2381.

43. LuL, PalaniyandiS, ZengR, BaiY, LiuX, et al. (2011) A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection. J Virol 85: 10542–10553.

44. MyerL, WrightTCJr, DennyL, KuhnL (2006) Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis 33: 683–687.

45. MossGB, ClemetsonD, D'CostaL, PlummerFA, Ndinya-AcholaJO, et al. (1991) Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J Infect Dis 164: 588–591.

46. JacobsonDL, PeraltaL, GrahamNM, ZenilmanJ (2000) Histologic development of cervical ectopy: relationship to reproductive hormones. Sex Transm Dis 27: 252–258.

47. PudneyJ, OnetaM, MayerK, SeageG (1992) Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet 340: 1470.

48. OwenDH, KatzDF (1999) A vaginal fluid simulant. Contraception 59: 91–95.

49. GrayRH, KigoziG, SerwaddaD, MakumbiF, WatyaS, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657–666.

50. CohenCR, LingappaJR, BaetenJM, NgayoMO, SpiegelCA, et al. (2012) Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 9: e1001251.

51. WilenCB, ParrishNF, PfaffJM, DeckerJM, HenningEA, et al. (2011) Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins. J Virol 85: 8514–8527.

52. TakedaA, SweetRW, EnnisFA (1990) Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. J Virol 64: 5605–5610.

53. RobinsonWEJr, MontefioriDC, MitchellWM (1988) Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1: 790–794.

54. GuillonC, SchuttenM, BoersPH, GrutersRA, OsterhausAD (2002) Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction. J Virol 76: 2827–2834.

55. BurtonDR, HessellAJ, KeeleBF, KlassePJ, KetasTA, et al. (2011) Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody. Proc Natl Acad Sci U S A 108: 11181–11186.

56. VeazeyRS, ShattockRJ, PopeM, KirijanJC, JonesJ, et al. (2003) Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 9: 343–346.

57. HessellAJ, HangartnerL, HunterM, HavenithCE, BeurskensFJ, et al. (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449: 101–104.

58. ForthalDN, GabrielEE, WangA, LanducciG, PhanTB (2012) Association of Fcgamma receptor IIIa genotype with the rate of HIV infection after gp120 vaccination. Blood 120: 2836–2842.

59. WrightA, LammME, HuangYT (2008) Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A. J Virol 82: 11526–11535.

60. TudorD, YuH, MaupetitJ, DrilletAS, BoucebaT, et al. (2012) Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody. Proc Natl Acad Sci U S A 109: 12680–12685.

61. ChomontN, HociniH, GodyJC, BouhlalH, BecquartP, et al. (2008) Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells. Virology 370: 246–254.

62. QiaoSW, KobayashiK, JohansenFE, SollidLM, AndersenJT, et al. (2008) Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A 105: 9337–9342.

63. BakerK, QiaoSW, KuoTT, AvesonVG, PlatzerB, et al. (2011) Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc Natl Acad Sci U S A 108: 9927–9932.

64. LiuX, LuL, YangZ, PalaniyandiS, ZengR, et al. (2011) The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. J Immunol 186: 4674–4686.

65. SiddappaNB, WatkinsJD, WassermannKJ, SongR, WangW, et al. (2010) R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models. PLoS One 5: e11689.

66. MantisNJ, PalaiaJ, HessellAJ, MehtaS, ZhuZ, et al. (2007) Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. J Immunol 179: 3144–3152.

67. CortiD, LangedijkJP, HinzA, SeamanMS, VanzettaF, et al. (2010) Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One 5: e8805.

68. TillerT, MeffreE, YurasovS, TsuijiM, NussenzweigMC, et al. (2008) Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 329: 112–124.

69. BurtonDR, PyatiJ, KoduriR, SharpSJ, ThorntonGB, et al. (1994) Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266: 1024–1027.

70. GachJS, QuendlerH, TongT, NarayanKM, DuSX, et al. (2013) A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1. PLoS One 8: e72054.

71. KeeleBF, GiorgiEE, Salazar-GonzalezJF, DeckerJM, PhamKT, et al. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552–7557.

72. KrausMH, ParrishNF, ShawKS, DeckerJM, KeeleBF, et al. (2010) A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays. Virology 397: 346–357.

73. Jackson S MJ, Moldoveanu Z, Spearman P. (2005) Appendix I: Collection and processing of human mucosal secretions. ; Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W., editor. Amsterdam: Elsevier/Academic Press.

74. MoldoveanuZ, MesteckyJ (2009) Mucosal antibody responses to HIV. Methods Mol Biol 485: 333–345.

75. PudneyJ, QuayleAJ, AndersonDJ (2005) Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 73: 1253–1263.